Castleark Management LLC maintained its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 12,820 shares of the medical instruments supplier’s stock at the close of the second quarter. Castleark Management LLC’s holdings in DENTSPLY SIRONA were worth $831,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. Commonwealth Bank of Australia increased its holdings in shares of DENTSPLY SIRONA by 19.0% in the 2nd quarter. Commonwealth Bank of Australia now owns 1,626 shares of the medical instruments supplier’s stock valued at $104,000 after acquiring an additional 260 shares during the period. Acrospire Investment Management LLC purchased a new position in shares of DENTSPLY SIRONA in the 2nd quarter valued at $113,000. Dupont Capital Management Corp purchased a new position in shares of DENTSPLY SIRONA in the 2nd quarter valued at $116,000. Korea Investment CORP increased its holdings in shares of DENTSPLY SIRONA by 139.9% in the 2nd quarter. Korea Investment CORP now owns 2,145 shares of the medical instruments supplier’s stock valued at $139,000 after acquiring an additional 1,251 shares during the period. Finally, Sphera Funds Management LTD. purchased a new position in shares of DENTSPLY SIRONA in the 2nd quarter valued at $162,000. Institutional investors and hedge funds own 93.87% of the company’s stock.

Shares of DENTSPLY SIRONA Inc. (XRAY) traded down 0.2407% on Tuesday, reaching $59.0475. The company had a trading volume of 56,757 shares. The firm’s 50 day moving average is $57.94 and its 200 day moving average is $61.07. DENTSPLY SIRONA Inc. has a 12 month low of $52.54 and a 12 month high of $65.68. The firm’s market capitalization is $13.55 billion.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $0.65. DENTSPLY SIRONA had a positive return on equity of 7.24% and a negative net margin of 20.57%. The firm had revenue of $992.70 million for the quarter, compared to analyst estimates of $1 billion. During the same quarter last year, the company posted $0.76 earnings per share. The business’s revenue was down 2.9% on a year-over-year basis. On average, equities research analysts expect that DENTSPLY SIRONA Inc. will post $2.68 earnings per share for the current fiscal year.

A number of brokerages have recently issued reports on XRAY. HC Wainwright reiterated a “buy” rating and issued a $68.00 price target (down from $74.00) on shares of DENTSPLY SIRONA in a report on Monday, August 14th. TheStreet downgraded DENTSPLY SIRONA from a “b” rating to a “c+” rating in a report on Wednesday, August 9th. Morgan Stanley lifted their price target on DENTSPLY SIRONA from $66.00 to $67.00 and gave the company an “overweight” rating in a report on Thursday, August 10th. Zacks Investment Research upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $72.00 price target on the stock in a report on Thursday, July 13th. Finally, BidaskClub downgraded DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Wednesday, July 19th. Two analysts have rated the stock with a sell rating, four have issued a hold rating and five have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $65.89.

COPYRIGHT VIOLATION NOTICE: “Castleark Management LLC Has $831,000 Stake in DENTSPLY SIRONA Inc. (XRAY)” was originally published by Daily Political and is the sole property of of Daily Political. If you are accessing this piece of content on another website, it was copied illegally and republished in violation of US & international copyright laws. The correct version of this piece of content can be viewed at https://www.dailypolitical.com/2017/10/17/castleark-management-llc-has-831000-stake-in-dentsply-sirona-inc-xray.html.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.